A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening
Journal Title: International STD Research & Reviews - Year 2017, Vol 6, Issue 1
Abstract
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination administered in Ecuador, and to estimate the cost-saving of preventing GW while preventing cervical cancer with both vaccines. Study Design: We used a previously developed transmission dynamic mathematical model to evaluate the impact of routine vaccination of 9-11 year-old females. The model assumed coverage of 90% for two doses of HPV6/11/16/18 vaccine at international price rates versus HPV16/18 vaccine and costs for genital warts treatment. Other simulation parameters include: country socio- demographic variables, sexual behavior and screening parameters among Ecuadorian girls. Results: Over a 100-year period, HPV6/11/16/18 vaccination would result in reductions of HPV 6/11-related disease incidence at the population level as follows: genital warts in females (81.3%), genital warts in males (78.9%) and HPV6/11-related CIN1 (79.7%). These results would translate into a reduction of HPV 6/11-related disease cost of between 52% to 56% for genital warts among females, genital warts among males, and HPV6/11-related CIN1. Under the model assumptions, the estimated net cost of vaccination with the HPV6/11/16/18 vaccine from a public health perspective would be close to -USD$256 million. Adjusted to the net present value, this cost-saving represents USD$180,735,849.09 with a present value interest factor of 0.9512. Conclusions: In Ecuador, routine vaccination of 9-11 year old females with a quadrivalent HPV6/11/16/18 vaccine is cost-saving compared to a bivalent HPV 16/18 vaccine, which suggests a significant public health and economic impact.
Authors and Affiliations
Maria Isabel Roldós, Isabel Espinosa, Amit Kulkarni, Matthew Pillsbury, Andrew Pavelyev, Homero A. Monsanto, Diego Guarín, Miguel Cashat-Cruz
Keywords
Related Articles
- EP ID EP305407
- DOI 10.9734/ISRR/2017/35382
- Views 111
- Downloads 0
Effect of HIV Infection and Antiretroviral Therapy Duration on CD4 Count, Total and Differential White Cell Count
Aims: To assess CD4 counts, total and differential white cell counts in HIV positive patients on antiretroviral treatment (ART) and those not on antiretroviral treatments with varying durations of infection. Study Design...
Sexually Transmitted Infections among Female Sex Workers in Some Selected Region of Bayelsa State
This study investigated some sexually transmitted infections (STIs) among some most at risk population (MAPS) in Bayelsa state. Blood samples were collected from 156 (one hundred and fifty six apparently healthy female s...
Sexually Transmitted Diseases: Knowledge and Perceived Prevalence of Symptoms in University Students
Background: Research addressing knowledge on sexual health, particularly of STDs risk and perceived symptoms’ prevalence, among university students around the world, and particularly in Portugal, is scarce. Aims: The aim...
Chlamydial Proctitis in Patients with Chlamydial Cervicitis
Aims: We investigated the status of chlamydial proctitis, detected using a transcription-mediated amplification (TMA) method, in rectal mucosal swab samples from patients with chlamydial cervicitis. Methodology: Patients...
The Effects of HAART on the Renal Functions of HIV Positive Patients in Nsukka, South East Nigeria
Background: Renal failure is highly prevalent among persons with Human Immuno Deficiency virus (HIV) infection and is linked to high morbidity and mortality rate. Aim: The aim of this study was to determine the effect o...